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Background: This study was conducted to determine the prevalence of a low appendicular skeletal muscle index
(ASMI) using three cut-off points (mean ASMI-2SD of a gender-specific young reference group (aged 18–39 years),
mean ASMI-1SD of a gender-specific young reference group, and the lower 20 percentile value of a gender-specific
older group (aged≥ 65 years)) in Korean older people and the relationship between ASMI and subjective health-related
quality of life.
Methods: This study utilized data acquired during the Korean National Health and Nutrition Examination Survey
(KNHANES) from 2008–2011. Dual-energy X-ray absorptiometry body compositional data was obtained from a
subsample of 6538 subjects (men 2804, women 3734) aged 18–39 and 4413 subjects (men 1872, women 2541)
aged 65 years and older. The three definitions of low appendicular skeletal muscle and the EQ-5D-3 L-Korean
descriptive system were applied to Korean older people.
Results: For the ASMI cutoff points used, in men, the three cutoff points were ASMI 2SD (6.09 kg/m2), ASMI 20
(6.48 kg/m2), and ASMI 1SD (6.95 kg/m2). In women, ASMI 2SD (4.38 kg/m2) was the lowest, followed by ASMI
1SD (4.96 kg/m2) and ASMI 20 (5.33 kg/m2). Proportions of older subjects with a low ASMI using the three cutoff
points were 9.7% (ASMI 2SD) and 40.9% (ASMI 1SD) in men, and 0.7% (ASMI 2SD) and 7.4% (ASMI 1SD) in women.
By multivariate ordinal logistic regression analysis, men with a low ASMI had significantly high odd ratios for the
three domains of mobility (p < 0.001), self-care (p = 0.005), and usual activities (p = 0.004) among the five domains
of the EQ-5D and EQ-5D index (p = 0.010).
Conclusions: The ASMI 2SD cut-off points for older Koreans, 6.09 kg/m2 for men and 4.38 kg/m2 for women, resulted
in low prevalences of a low ASM, that is, 9.7% for men and 0.7% for women, and showed low clinical usefulness due to
very low determined prevalence in women. Hence, we suggest that the cut-off point of the lowest 20% of Korean older
people (men: 6.48 kg/m2, women; 5.33 kg/m2) be used for older Koreans.
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Life expectancies are increasing in most ethnic groups
and countries, as are the survivals of older people with
impaired physical functions and disabilities [1,2]. Ac-
cordingly, there is a great deal of research interest in
precursors, including sarcopenia, in older people with
impaired physical functions and disabilities [3,4].
Sarcopenia is a term applied by Irwin Rosenberg in 1989
to explain age-associated loss of muscle mass and muscle
function [5]. Thereafter, researchers have added impaired
functional performance and/or muscle weakness of
clinical importance to the loss of muscle mass incorpo-
rated in the concept of sarcopenia. The Foundation for
the National Institute of Health (FNIH) Sarcopenia
Project defined sarcopenia as clinically relevant low
muscle strength (weakness) and low lean mass in 2014
[6]. The Asian Working Group for Sarcopenia (AWGS)
guideline also addressed cut-off points for Asian older
people by modifying the European Working Group on
Sarcopenia in Older People (EWGSOP) guideline [7].
The EWGSOP, International Working Group in Sarco-
penia (IWGS) and AWGS guidelines define the sum of
the muscle masses of the four limbs as appendicular
skeletal mass (ASM) to calculate appendicular skeletal
mass index (ASMI) as ASM/height2 (ASM/m2) [3,4,8-10].
However, many other cutoff points have been proposed
[11]. Previous studies among Asian older people showed
substantially different cutoff points for low ASMI. Further-
more, the prevalences of low ASMI among Asian women
were extremely low, which caused problems for re-
searchers conducting studies on sarcopenia.
This study was conducted to determine the prevalence
of low ASMI in accordance with three cutoff points in
aged Korean (>65 years), and to explore the relationship




This study was based on data obtained from the 2008–
2011 Korean National Health and Nutrition Examination
Survey IV and V (KNHANES), a nationally-representative
survey conducted by the Korean Ministry of Health and
Welfare. KNHANES was a nationwide cross-sectional
survey conducted in 1998–2012 by the Korean Center
for Disease Control and Prevention (KCDC). KNHANES
used stratified multi-stage clustered probability sampling
to reflect the non-institutionalized Korean population.
Participants completed a questionnaire that consisted of a
health interview survey, a health behavior survey, a nutri-
tion survey, and a health examination survey. A whole
body dual energy X-ray absorptiometry (DXA) scan were
performed on individuals ≥20 years old from July 2008 to
June 2009 and on individuals of ≥10 years old fromJuly 2009 to May 2011 (excluding pregnant women), indi-
viduals with a height of ≥196 cm or a weight of ≥136 kg
were excluded in accord with the KNHANES survey
protocol. In addition, test results were treated as missing
value in participants with implanted radio-opaque material
(e.g., a prosthetic device, implant or other radio-opaque
object) that could affect DXA results [12].
After excluding those without a whole body DXA scan
(aged 18–39 years: 123 men and 214 women, aged 65–97
years: 105 men and 143 women), 6538 subjects (aged
18–39 years: 2,804 men, 3,743 women; the young reference
group) and 4413 subjects (aged 65–97 years: 1872 men,
2541 women; the main analysis group) were included in the
final analysis. Written informed consent was given by all
participants and the protocol for KNHANES IV and V were
approved by the Institutional Review Board of the KCDC
(2008-04EXP-01-C, 2009-01CON-03-2C, 2010-02CON-21-C,
2011-02CON-06-C). Current study did not require additional
Institutional Review Board approval because the KNHANES
data set is publicly available.
DXA measurements
In the KNHANES study, whole body DXA examinations
were conducted with a QDR4500A apparatus (Hologic,
Bedford, MA, USA). All participants wore light clothing
and removed all jewelry and other items that could inter-
fere with DXA. The KNHANES data includes values for
bone mineral content (g), bone mineral density (g/cm2),
fat mass (g), lean mass (including bone mineral content
(g)), and fat percent (%) for whole body and anatomical
regions. From this data, ASM (kg) was calculated by
summing the muscle masses of the four limbs, assuming
that all non-fat and non-bone mass is skeletal muscle.
ASMI was defined as ASM/height2 [13].
Definition of low ASMI
The following exclusion criteria were applied to the 6538
eligible subjects (aged 18 to 39 years), a prior diagnoses or
treatment for diabetes, stroke, angina, myocardial infarc-
tion, thyroid disease, arthritis, asthma, chronic obstructive
pulmonary disease, depression, chronic renal disease,
chronic viral hepatitis, liver cirrhosis, or any malignancy. In
addition, subjects hospitalized for any reason during the
past year were also excluded (n = 1835). A total of 4703
(men 2096, women 2607) were recruited for the young
(18–39 years) reference group. Low ASMI groups were
defined using the following three cutoff point points: ASMI
2SD - the cutoff value of the lowest 2.28% in gender-
specific young reference groups, ASMI 1SD - the cutoff
value of the lowest 15.87% in gender-specific young refer-
ence groups, and ASMI 20 - the cutoff value of the lowest
20% in gender-specific older study participants.
Unlike previous studies, ASMI values of the young
reference group in the current study were not normally
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kurtosis, we used approximate values (2.28%, and 15.87%)
in place of 1SD and 2SD values, respectively. These
approximate values can be used in non-normally
distributed data, whereas values of 1SD and 2SD can be
used in normally distributed data [14].
EQ-5D-3 L -Korean (EQ-5D)
To measure health-related quality of life, we used the
European Quality of Life-5 Dimensions (EQ-5D) instru-
ment of the EuroQol group [15]. Validity of Korean version
of EQ-5D (Spearman correlation coefficient with the first
question of the Health Survey Short-Form 36: −0.51 in
EQ-5D and −0.52 in EQ-VAS) and reliability (test–retestFigure 1 EQ-5D 3 (EQ-5D) questionnaire. Reproduced from [Journal of N
2000] with permission from EuroQol Group and BMJ Publishing Group Ltd.reliabilities using intra-class correlation: 0.75 in EQ-5D
and −0.77 in EQ-VAS; agreement reliability using kappa
statistics between 0.46 and 0.77) have already been dem-
onstrated [16]. EQ-5D measures five single-item dimen-
sions (mobility, self-care, usual activities, pain/discomfort,
and anxiety/depression), each item has three levels of
response (no, some, or extreme problems) (Figure 1).
Responses to the five items are used to derive an overall
health index score (using the weighting). In this study, we
used the weighting suggestion of Nam et al. [17].
Covariates
The covariates included in the analysis were age, educa-
tion, family income, body mass index (BMI), smokingeurology, Neurosurgery & Psychiatry, Schrag. A. et al., 69(1), 67–73,
[18].
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of chronic illness. BMI was used to assess obesity as de-
termined by the World Health Organization Asia-Pacific
criteria: underweight (BMI <18.5 kg/m2), normal weight
(BMI: 18.5-22.9 kg/m2), overweight (BMI: 23.0-27.4 kg/m2),
and obese (BMI ≥27.5 kg/m2) [19]. Smoking status was
categorized into four groups: never smokers (fewer than
100 cigarettes smoked during life), passive smokers
(exposed to second-hand smoke for more than 1 hour a
day in the home or workplace), current smokers, and
former smokers. Alcohol consumption was assessed
using the Korean version of the Alcohol Use Disorders
Identification Test (AUDIT-K) and categorized based
on scores into normal alcohol consumption group (men
<9, women <5), harmful alcohol consumption group
(men: 10–19, women: 6–9), and a suggestive alcohol
dependent group (men >20, women >10) [20]. Chronic
illnesses considered were cancer, diabetes, hypertension,
stroke, coronary artery disease, arthritis, chronic pul-
monary disease, depression, chronic renal failure, and
chronic viral hepatitis/liver cirrhosis. These conditions
were considered present when diagnosed by a physician
at any time. We defined number of chronic illness
as the sum of number of illness among the checklist of
chronic illness.
Statistical analyses
Statistical analyses were conducted using the complex
sample procedure because the KNHANES data set was
selected using a representative, stratified, and clusteredTable 1 Anthropometric characteristics of the healthy young
Men
Young reference group ≥
Sample size (no.) 2096 1
Weighted size (no.) 6392302 2
Age (years) 29 (18–39) 7
Height (cm) 173.67 ± 5.651 1
Weight (kg) 71.39 ± 11.241 6
Waist circumference (cm) 81.29 ± 9.250 8
Body mass index (kg/m2) 23.65 ± 3.415 2
Total fat mass (kg) 15.54 ± 6.248 1
Total body fat percentage (%) 21.40 ± 6.020 2
ASM (kg) 23.60 ± 3.190 1
ASMI (kg/m2) 7.81 ± 0.909 7
ASMI 2SD cutoff point 6.09
ASMI 1SD cutoff point 6.95
ASMI 20 cutoff point 6
Weighted sample size reflects the number of objects and sample weights. Age is ex
ASM = appendicular skeletal muscle mass. ASMI = appendicular skeletal muscle inde
the following three cut-off points: ASMI 2SD - the value of the lowest 2.28% of the
15.87% of the gender-specific young reference group, and ASMI 20 - the value of losampling method, not a random sampling method. The
data in Table 1 were analyzed after weighting, because we
needed sample distributions, such as, SDs and percentile
values, for detailed ASMI analysis. Using these data, we
determined low ASMI group depending on ASMI 1SD
and ASMI 2SD and ASMI 20 value. Thereafter, univariate
and multivariate analyses and ordinal regression analysis
was performed using the five domains of EQ-5D and
EQ-5D index as dependent variables and ASMI groups as
independent variables. Because of a previously reported
gender effect between ASMI and clinical outcomes, uni-
variate and multivariate analyses were performed in each
gender group [6]. In multivariate analysis, factors associ-
ated with ADL or IADL in previous studies, status of
obesity using BMI, smoking, AUDIT-K, chronic illness,
and numbers of chronic disease, were considered add-
itional independent variables. Education level and family
income, which are known to be significantly associated
with EQ-5D, were also considered independent variables
[17]. Here a backward elimination procedure was used.
Accordingly, to this procedure, nonsignificant covariates
(p > 0.10) were removed from the model until a final solu-
tion was reached. Statistical significance was accepted for
p values of <0.05. SPSS ver. 21.0 (SPSS, Chicago, IL, USA)
was used for the statistical analysis.
Results
Mean and SD of ASMI in the young men group assum-
ing a normal distribution was 7.81 ± 0.91 kg/m2 and in
the young women group was 5.67 ± 0.78 kg/m2. If ASMIreference group and older study group by gender
Women
65 years Young reference group ≥65 years
872 2607 2541
152083 5580819 3126111
1 (65–93) 29 (18–39) 72 (65–97)
64.81 ± 5.745 160.61 ± 5.406 150.47 ± 5.764
2.81 ± 9.485 56.04 ± 9.520 54.62 ± 9.044
4.62 ± 9.036 72.44 ± 9.011 83.25 ± 9.562
3.07 ± 2.925 21.72 ± 3.495 24.07 ± 3.398
4.32 ± 4.896 17.81 ± 5.782 18.85 ± 5.651
2.56 ± 5.434 31.47 ± 5.585 34.13 ± 5.935
9.44 ± 2.756 14.66 ± 2.228 13.36 ± 1.905




pressed as median (min-max). Other results are expressed as means ± SDs.
x. Low ASMI groups were defined as subjects whose ASMIs were lower than
gender-specific young reference group, ASMI 1SD - the value of the lowest
west 20% of the gender-specific old age study group.
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values of mean-2SD and the lowest 2.28% would have
been the same. However, young men group (Kolmogo-
rov-Smirnov p = 0.020) and the young women group
(Kolmogorov-Smirnov p < 0.001) did not show a normal
distribution due to high kurtosis. In the young men group,
the mean-2SD value was 5.99 kg/m2 and the lowest 2.28%
value was 6.09 kg/m2, and in the young women group
corresponding values were 4.12 kg/m2 and 4.38 kg/m2,
respectively. The difference between the two values was
higher in the young women group (0.26 kg/m2 vs. 0.10
kg/m2). The ASMI cutoff points in older men were ASMI
2SD (6.09 kg/m2), ASMI 20 (6.48 kg/m2), and ASMI 1SD
(6.95 kg/m2), and corresponding values for older women
were ASMI 2SD (4.38 kg/m2), ASMI 1SD (4.96 kg/m2), and
ASMI 20 (5.33 kg/m2) (Table 1). Characteristics of the
older study participants are summarized in Table 2. The
proportions in low group for each cutoff point for older
men study subjects were 9.7% (ASMI 2SD) and 40.9%
(ASMI 1SD), respectively, and for older women were
0.7% (ASMI 2SD) and 7.4% (ASMI 1SD), respectively
(Table 3). By univariate analysis with ordinal regression
analysis using the complex sample procedure, low
ASMI had significantly associated with poorer outcome
of five domains of EQ-5D and of the EQ-5D index in
older men. More specifically, ASMI ranging from ASMI
2SD to ASMI 20 had higher cumulative odds ratios
(ORs) than those with those a normal ASMI [mobility
2.28 (95% Confidence Interval (CI): 1.55-3.35), self-care
(OR 2.10, CI: 1.10-4.00), usual activities (OR 2.40, CI:
1.53-3.77), pain/discomfort (OR 1.63, CI:1.13-2.36), anx-
iety/depression (OR 1.76, CI:1.01-3.09), and EQ-5D index
(OR 2.09, CI: 1.45-3.02)] in older men (Table 4). Low
ASMI had significantly associated with poorer outcome of
domains of self-care and anxiety/depression among the
five domains of EQ-5D in older women. More specifically,
ASMIs ranging from ASMI 2SD to ASMI 20 had a higher
OR for difficulty in self care (OR 1.20, CI: 0.82-1.74) and
prevalence of anxiety/depression (OR 0.78, CI: 0.54-1.12)
in older women (Table 5).
By multivariate ordinal logistic regression, low ASMI had
significantly higher ORs for the three domains of mobility,
self-care, and usual activities among the five domains of
EQ-5D in older men (Table 4). In detail, the findings with
ASMI 20 were mobility (OR 2.54, CI: 1.63-3.95), usual
activities (OR 2.31, CI: 1.31-4.09), and EQ-5D index (OR
1.86, CI: 1.23-2.82) in older men (Table 6). However these
correlations were not significant for all three cutoff points
ASMI 2SD, ASMI 1SD (except ASMI 2SD), and ASMI 20
(except ASMI 1SD) in older women (Table 7).
Discussion
In this Korean national representative sample, the preva-
lences of low ASMI according to a cutoff point of ASMI2SD were 9.7% and 0.7% for older (≥65 years) men and
women, respectively, however, according to cutoff point
of ASMI 1SD, 40.9% and 7.4% of the older men and
women, respectively, had a low ASMI. In addition, only
older men with a low ASMI were found to have a low
health-related quality of life.
The means and SDs of ASMI were 7.14 ± 0.81 kg/m2
and 5.89 ± 0.66 kg/m2 in older Korean men and women,
respectively, which are a little lower than those of previ-
ous studies. The New Mexico Elder Health Survey for
Hispanic and non-Hispanic Americans conducted from
May 1993 to September 1995 reported a mean ASMI
was 7.7 ± 0.7 kg/m2 in older men and 5.9 ± 0.7 kg/m2 in
older women [13]. The Health ABC study on Americans
conducted from 1997 to 1998 reported a mean ASMI in
European Americans of 7.8 ± 0.9 kg/m2 in older men and of
6.1 ± 0.8 kg/m2 in older women [21]. A Japanese study con-
ducted from July 2002 to June 2003 reported mean ASMIs
of 7.61 ± 0.7 kg/m2 in older men and 6.32 ± 0.6 kg/m2 in
older women [22]. Finally, a study in Taiwan published in
2013 reported mean ASMIs of 7.6 ± 0.8 kg/m2 and 6.4 ±
0.6 kg/m2 in older men and women, respectively [23].
On the other hand, mean ASMIs in the young refer-
ence group in the present study were 7.81 ± 0.91 kg/m2
and 5.67 ± 0.78 kg/m2 in men and women, which are
markedly lower than the values obtained in the American
study, which reported mean ASMIs for a young reference
group (18–40 years) of 8.6 ± 1.1 kg/m2 and 7.3 ± 0.9 kg/m2
in men and women [13]. The present findings are also
lower than those in the Taiwanese study, which reported
mean ASMIs in a disease-free young reference group
(20–40 years) of 8.2 ± 0.9 kg/m2 and 5.9 ± 0.8 kg/m2 in
men and women [23].
In The New Mexico Elder Health Survey for Hispanic
and non-Hispanic Americans, the mean ASMIs of older
men and women were approximately at the 87 and 80 per-
centiles, respectively, of the young reference group [13]. In
our study, the mean ASMIs of older men and women were
at the 91 and 104 percentiles, of the young reference group,
and the mean ASMI of older women was higher than the
mean ASMI of the young woman reference group.
The proportion of older people with an ASMI two stand-
ard deviations below the mean ASMI of the young refer-
ence group also displayed a marked difference in the
present study as compared with previously published values.
In our study, older people with below ASMI 2SD were 9.7%
in older men and 0.7% in older women, as compared to
13% at 61 to 70 years of age, 24% at 71 to 80 years of age,
and 50% at aged 81 aged and older [13], and 28% in men
≥70 years of age and 52% in women ≥70 years of age [24].
Interestingly, many studies on sarcopenia in Asian
populations have not used the standard ASMI cutoff of
two standard deviations below the mean ASMI of the
young reference group. The ASMI 1SD cutoff points
Table 2 General characteristics of older study participants by gender
Men Women
Sample size (no.) 1872 2541
Weighted size (no.) 2152083 3126111
Education
None 4.0 (0.6) 17.6 (1.2)
Elementary school 24.1 (1.4) 45.3 (1.3)
Middle school 29.1 (1.4) 26.7 (1.2)
High school 20.3 (1.2) 6.6 (0.6)
Over college grade 22.5 (1.4) 3.8 (0.5)
Family income
1st quartile 53.9 (1.2) 56.8 (1.4)
2nd quartile 23.1 (0.8) 20.5 (1.0)
3rd quartile 13.0 (0.8) 12.7 (0.9)
4th quartile 9.9 (0.8) 10.0 (0.9)
BMI (kg/m2)
Underweight (<18.5) 6.1 (0.7) 3.9 (0.5)
Normal weight (18.5-22.9) 43.5 (1.5) 33.8 (1.2)
Overweight (23.0-27.4) 42.8 (1.4) 47.6 (1.3)
Obese (>27.5) 7.5 (0.8) 14.7 (0.8)
Smoking
Never Smoking (<100 cigarettes in life) 17.9 (1.0) 85.8 (0.9)
Passive smoking (>1 hour/day) 0.6 (0.2) 2.8 (0.4)
Former smoker 27.8 (1.4) 2.4 (0.5)
Current Smoker 53.7 (1.5) 9.0 (0.7)
Audit-K
Normal 70.5 (1.5) 92.8 (0.8)
harmful alcohol consumption 22.4 (1.2) 4.6 (0.7)
suggestive of alcohol dependence 7.1 (0.9) 2.6 (0.5)
Chronic illness
Cancer 6.4 (0.7) 5.8 (0.6)
Diabetes 16.3 (0.9) 18.1 (1.0)
Hypertension 41.4 (1.4) 54.4 (1.3)
Stroke 7.3 (0.7) 4.2 (0.4)
Coronary artery disease 6.3 (0.6) 5.2 (0.5)
Arthritis 13.9 (1.0) 44.9 (1.2)
Chronic Pulmonary Disease 6.0 (0.6) 6.7 (0.6)
Depression 2.3 (0.4) 6.2 (0.6)
Chronic renal failure 0.6 (0.2) 0.6 (0.1)
Chronic hepatitis/Liver cirrhosis 2.5 (0.4) 1.2 (0.3)
No. of chronic illness 1.03 (0.98-1.09) 1.47 (1.42-1.53)
Weighted sample size reflects the number of objects and the sample weights. Results are expressed as percentages (standard errors). Numbers of chronic illnesses
are expressed as means (95% Confidence Index).
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men and 5.21 kg/m2 in women and 7.09 kg/m2 in men
and 5.27 kg/m2 in women, while a study in Taiwan used
the lower 20 percentile values of gender specific healthyyoung age individuals [22,23,25]. Considering the diag-
nostic criteria of sarcopenia recommended by the IWGS,
EWGSOP, and AWGS, these sets of research standards
are atypical. It is possible that the use of the ASMI 2SD
Table 3 Prevalence of low ASMI and EQ-5D for older
study participants by gender
Men Women
Sample size (no.) 1872 2541
Weighted size (no.) 2152083 3126111
ASMI
ASMI 2SD 9.7 (0.9) 0.7 (0.2)
ASMI 1SD 40.9 (1.5) 7.4 (0.7)
ASMI 20 20.0 (1.2) 20.0 (1.1)
EQ5D
Mobility
No problem 65.4 (1.4) 42.8 (1.3)
Some problems 32.9 (1.3) 53.4 (1.3)
Extreme problems 1.7 (0.4) 3.8 (0.5)
Self-Care
No problem 90.4 (0.9) 80.9 (1.0)
Some problems 8.6 (0.8) 17.4 (1.0)
Extreme problems 1.0 (0.2) 1.7 (0.3)
Usual Activities (e.g., work, study, housework, family or leisure activity)
No problem 76.6 (1.3) 61.9 (1.2)
Some problems 19.9 (1.2) 31.5 (1.1)
Extreme problems 3.5 (0.5) 6.6 (0.7)
Pain/Discomfort
No problem 67.3 (1.3) 47.3 (1.3)
Some problems 26.9 (1.2) 38.2 (1.2)
Extreme problems 5.8 (0.6) 14.5 (0.8)
Anxiety/Depression
No problem 88.9 (0.9) 79.5 (1.0)
Some problems 9.3 (0.7) 17.4 (0.9)
Extreme problems 1.9 (0.5) 3.2 (0.4)
EQ5D index
1 52.6 (1.4) 28.9 (1.1)
0.775-0.999 26.8 (1.3) 33.5 (1.3)
<0.774 20.6 (1.2) 37.7 (1.3)
The weighted sample size reflects the number of objects and the sample weights.
Results are expressed as percentages (standard errors). Low ASMI groups were
defined as subjects whose ASMIs were lower than the following three cut-off
points: ASMI 2SD - the value of the lowest 2.28% of the gender-specific young
reference group, ASMI 1SD - the value of the lowest 15.87% of the gender-specific
young reference group, and ASMI 20 - the value of lowest 20% of the
gender-specific old age study group.
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would have resulted in an unacceptably small proportion
of sarcopenic older individuals. Other studies in Asians
may have been similarly hampered.
A number of reasons can be suggested for the low
proportions of older people with an ASMI 2SD below the
mean ASMI of young reference groups in the present
study. First, the body types of Koreans are changing due
to improvements in living standards. According to the2010 Size-Korea survey of body measurement, the average
height of Koreans increased steadily up to 2003 and
remained constant thereafter, whereas the body types of
Koreans have consistently changed. In that survey, the
proportion of body shape of Korean 20s women changed
to 7.3-head units tall as compared with 20 years earlier a
7.2-head units tall, and leg lengths of Korean women were
nearly 2 centimeters longer than 30 years earlier [26].
Second, Korean women in their 20s and 30s can have poor
weight reducing habits, and rely diet restriction rather
than exercise. This reflects a distorted body image, with a
desire to have a body type similar to Caucasian women,
Korean women tend to prefer a slim body with focus on
diet restriction, have a negative effect on muscle develop-
ment [27-29]. As a result, muscle mass in Korean women
has been consistently reported to be decreasing more so
than body fat because of repetitive low calorie diets and
accompanying cycles of weight loss and weight gain
[27,30,31]. These results are consistent with the results of
the Size-Korea survey, which found that mean BMI of
subjects in their late 20s significantly decreased over time
and the proportion of underweight individuals (as deter-
mined by BMI) increased to 15.7% in 2010 from 11.5% in
2003, while decreases in waist circumference was not
significant over the same period [26]. As a result, in the
present study, the mean ASMI of the young reference
women group was lower than the mean ASMI of the older
women group (≥65 years of age) and the proportion of
older women in the below ASMI 2SD group was exces-
sively low.
Because ASMI values of the young reference group in
the current study did not show a normal distribution,
we used alternative values that corresponded to lowest
2.28% and 15.87% values in the young reference group in
place of 1SD and 2SD values, respectively. After making
this adjustment, the cutoff point of ASMI 2SD increased
from 4.12 kg/m2 to 4.38 kg/m2 in older women, and had
we applied the real ASMI 2SD value (4.12 kg/m2) only
four older women would have had a low ASMI.
It is suggested that the existing sarcopenia diagnostic
criteria using ASMI of a young reference group of the
same gender and race is inadequate for Koreans. Consid-
ering clinical outcomes later in life, re-establishment of
optimal ASMI cut-off points is needed.
We performed multivariate ordinal logistic regression
analysis to examine the association between the low
ASMI group based on the three established ASMI cutoff
points mentioned and EQ-5D determined health-related
quality of life. Low ASMI had significantly associated
with poorer outcome of three domains of mobility, self-
care, and usual activities among the five domains of the
EQ-5D in older men. However, in older women with a
low ASMI, these correlations were not significant for
any of the three ASMI cutoff points. These findings are
Table 4 Univariate analysis of five domains of EQ-5D and EQ5D index according to ASMI in older men
Estimates Standard error Cumulative odds ratio 95% CI p value
Mobility <0.001*
ASMI 2SD 0.818 0.192 2.267 1.554-3.308 <0.001
ASMI 20 0.824 0.195 2.280 1.554-3.346 <0.001
ASMI 1SD 0.311 0.159 1.365 0.998-1.867 0.051
Normal Reference
Self-care <0.001*
ASMI 2SD 1.152 0.250 3.165 1.938-5.169 <0.001
ASMI 20 0.743 0.328 2.103 1.104-4.007 0.024
ASMI 1SD 0.252 0.294 1.286 0.721-2.294 0.393
Normal Reference
Usual activities <0.001*
ASMI 2SD 1.153 0.195 3.169 2.159-4.651 <0.001
ASMI 20 0.875 0.230 2.398 1.526-3.767 <0.001
ASMI 1SD 0.500 0.181 1.648 1.156-2.350 <0.001
Normal Reference
Pain/discomfort 0.010*
ASMI 2SD 0.576 0.196 1.778 1.209-2.615 0.004
ASMI 20 0.490 0.188 1.632 1.128-2.362 0.009
ASMI 1SD 0.192 0.148 1.212 0.906-1.621 0.194
Normal Reference
Anxiety/depression 0.012*
ASMI 2SD 0.788 0.272 2.199 1.289-3.752 0.004
ASMI 20 0.567 0.286 1.763 1.006-3.090 0.048
ASMI 1SD 0.338 0.227 1.402 0.899-2.188 0.136
Normal Reference
EQ5D index <0.001*
ASMI 2SD 0.879 0.161 2.408 1.755-3.304 <0.001
ASMI 20 0.736 0.187 2.088 1.445-3.016 <0.001
ASMI 1SD 0.305 0.142 1.357 1.028-1.792 0.031
Normal reference
The weighted sample size reflects the number of objects and the sample weights. 95% CI: 95%.
Confidential Index for Cumulative Odds Ratio. *Adjustment for multiple comparisons was performed using the Sequential Sidak method. Low ASMI groups were
defined as subjects whose ASMIs were lower than the following three cutoff points: ASMI 2SD - the value of the lowest 2.28% of the gender-specific young
reference group, ASMI 1SD - the value of the lowest 15.87% of the gender-specific young reference group, and ASMI 20 - the value of lowest 20% of the
gender-specific old age study group.
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http://www.biomedcentral.com/1471-2318/14/144consistent with previous finding of a stronger correlation
between sarcopenia and functional decline and disability
in older men [4]. Additional studies about gender-
associated differences in muscle aging are needed.
Although the association between the low ASMI group
based on ASMI 20 and any domain of EQ-5D was not
significant in older women, the ASMI 20 cutoff point
was significantly associated with EQ-5D in older men.
On the other hand, the ASMI 2SD and ASMI 1SD cutoff
points may not be adequate to diagnose sarcopenia in
older Koreans because the proportions of older people
with sarcopenia are quite variable. Studies are needed onthe optimal ASMI cutoff point with respect to muscle
function and clinical outcome for Koreans. We suggest
that an ASMI 20 cutoff point (men 6.48 kg/m2, women
5.33 kg/m2) is appropriate for older people for the
assessment of low ASM, until an optimal cutoff point is
determined. Further studies on country/population
specific ASMI cutoff point are needed in different
communities.
This study had several strengths. First, our data were
collected from a nationwide survey that reflected the
community-dwelling Korean population. In particular,
because the young reference group was large (2096 men
Table 5 Univariate analysis of five domains of EQ-5D and EQ5D index according to ASMI in older women
Estimates Standard error Cumulative odds ratio 95% CI p value
Mobility 0.264*
ASMI 2SD 0.046 0.585 1.047 0.332-3.303 0.937
ASMI 1SD −0.102 0.227 0.903 0.579-1.410 0.654
ASMI 20 −0.242 0.146 0.785 0.589-1.045 0.097
Normal Reference
Self-care 0.011*
ASMI 2SD 1.634 0.561 5.122 1.702-15.418 0.004
ASMI 1SD 0.412 0.252 1.510 0.921-2.477 0.102
ASMI 20 0.179 0.190 1.196 0.824-1.737 0.345
Normal Reference
Usual activities 0.087*
ASMI 2SD 1.238 0.569 3.450 1.129-10.542 0.030
ASMI 1SD 0.188 0.220 1.206 0.784-1.857 0.394
ASMI 20 0.231 0.157 1.260 0.924-1.716 0.143
Normal Reference
Pain/discomfort 0.522*
ASMI 2SD 1.101 0.894 3.009 0.520-17.416 0.218
ASMI 1SD 0.057 0.191 1.058 0.728-1.539 0.767
ASMI 20 −0.080 0.144 0.923 0.695-1.225 0.578
Normal Reference
Anxiety/depression 0.021*
ASMI 2SD 1.498 0.555 4.471 1.504-13.290 0.007
ASMI 1SD 0.441 0.261 1.554 0.931-2.596 0.092
ASMI 20 −0.253 0.188 0.776 0.536-1.123 0.179
Normal Reference
EQ5D index 0.858*
ASMI 2SD 0.637 0.898 1.890 0.324-11.034 0.479
ASMI 1SD 0.087 0.211 1.091 0.721-1.650 0.681
ASMI 20 −0.006 0.152 0.994 0.738-1.340 0.969
Normal Reference
The weighted sample size reflects the number of objects and the sample weights. 95% CI: 95%.
Confidential Index for Cumulative Odds Ratio. *Adjustment for multiple comparisons was performed using the Sequential Sidak method. Low ASMI groups were
defined as subjects whose ASMIs were lower than the following three cutoff points: ASMI 2SD - the value of the lowest 2.28% of the gender-specific young
reference group, ASMI 1SD - the value of the lowest 15.87% of the gender-specific young reference group, and ASMI 20 - the value of lowest 20% of the
gender-specific old age study group.
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http://www.biomedcentral.com/1471-2318/14/144and 2607 women) and was nationally representative, the
ASMI distribution based on the young reference group
can be considered reliable. Second, we performed
analyses in a gender-specific manner. We found that the
association between height-adjusted ASM and EQ-5D
differed in older men and women, which is consistent
with the findings of the recent FNIH study, in which
height-adjusted ASM was found to be more useful for
men and weight-adjusted ASM for women with respect
skeletal muscle functions [6], implying a possible under-
lying gender effect.Finally, to our best knowledge, this study is the first report
of a significant association between low ASMI and health-
related quality of life. Our finding implies a possible relation-
ship between sarcopenia and health-related quality of life,
however, further studies are required to confirm the relation.
On the other hand, the present study has following
limitations that warrant consideration. First, the study
lacked investigation of cause-effect relationships because
of its cross-sectional nature. Future prospective cohort
studies are needed for such investigations. Second, previous
studies analyzed ADL and IADL as dependent variables,
Table 6 Multivariate analysis of five domains of EQ-5D and EQ5D index according to ASMI in older men
Estimates Standard error Cumulative odds ratio 95% CI p value
Mobility <0.001*
ASMI 2SD 0.698 0.272 2.010 1.117-3.431 0.011
ASMI 20 0.932 0.225 2.538 1.632-3.948 <0.001
ASMI 1SD 0.348 0.196 1.416 0.964-2.079 0.076
Normal Reference
Self-care 0.005*
ASMI 2SD 1.088 0.343 2.967 1.512-5.822 0.002
ASMI 20 0.637 0.397 1.890 0.867-4.121 0.109
ASMI 1SD 0.270 0.313 1.310 0.709-2.420 0.389
Normal Reference
Usual activities 0.004*
ASMI 2SD 1.082 0.335 2.950 1.526-5.701 0.001
ASMI 20 0.839 0.290 2.313 1.309-4.087 0.004
ASMI 1SD 0.539 0.213 1.714 1.128-2.606 0.012
Normal Reference
Pain/discomfort 0.465*
ASMI 2SD 0.385 0.292 1.469 0.828-2.609 0.188
ASMI 20 0.241 0.243 1.272 0.790-2.049 0.322
ASMI 1SD 0.113 0.180 1.120 0.786-1.595 0.530
Normal Reference
Anxiety/depression 0.836*
ASMI 2SD 0.140 0.352 1.150 0.576-2.295 0.691
ASMI 20 0.277 0.374 1.319 0.633-2.750 0.460
ASMI 1SD 0.199 0.264 1.220 0.726-2.050 0.453
Normal Reference
EQ5D index 0.010*
ASMI 2SD 0.656 0.247 1.928 1.187-3.132 0.008
ASMI 20 0.622 0.212 1.863 1.229-2.824 0.003
ASMI 1SD 0.204 0.168 1.227 0.882-1.707 0.224
Normal reference
The weighted sample size reflects the number of objects and the sample weights. 95% CI: 95%.
Confidential Index for Cumulative Odds Ratio. *Adjustment for multiple comparisons was performed using the Sequential Sidak method for obesity criteria, family
income, education, smoking, alcohol consumption criteria (AUDIT-K), chronic illness (cancer, diabetes, hypertension, stroke, coronary artery disease, arthritis, chronic
pulmonary disease, depression, chronic renal failure, chronic viral hepatitis/ liver cirrhosis), and number of chronic diseases. Low ASMI groups were defined as subjects
whose ASMIs were lower than the following three cutoff points: ASMI 2SD - the value of the lowest 2.28% of the gender-specific young reference group, ASMI 1SD - the
value of the lowest 15.87% of the gender-specific young reference group, and ASMI 20 - the value of lowest 20% of the gender-specific old age study group.
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http://www.biomedcentral.com/1471-2318/14/144whereas we used EQ-5D as a dependent variable.
Although EQ-5D contains items similar to ADL and
IADL, such as, mobility, self-care, and usual activities,
direct comparisons might be inappropriate. Third, we
did not consider muscle strength and muscle function
and we used only height-adjusted ASM. The recent
guidelines (EWGSOP, IWGS, AWGS and FNIH guide-
line) recommend to diagnose sarcopenia as reduced
muscle mass related to muscle strength and function
such as grip strength and gait speed, not only reducedmuscle mass itself. However, our KNHANES data set
did not contain information on muscle strength and
muscle function, thus we have analysed only muscle
mass in this study. Further studies are needed using
our suggested ASM cutoff point and the FNIH guide-
lines, which represent the state of the art, recommend
BMI-adjusted ASM. Finally, we did not include physical
activity as a potential confounder because KNHANES IV
and KNHANES V had different items of measurement.
Further studies on the topic are needed.
Table 7 Multivariate analysis of five domains of EQ-5D and EQ5D index according to ASMI in older women
Estimates Standard error Cumulative odds ratio 95% CI p value
Mobility 0.093*
ASMI 2SD −1.407 0.826 0.245 0.048-1.240 0.089
ASMI 1SD 0.157 0.299 1.170 0.650-2.106 0.599
ASMI 20 −0.469 0.218 0.626 0.408-0.961 0.032
Normal
Self-care 0.974*
ASMI 2SD −0.227 1.265 0.797 0.066-9.561 0.858
ASMI 1SD 0.136 0.360 1.146 0.565-2.325 0.705
ASMI 20 −0.042 0.288 0.959 0.544-1.689 0.884
Normal
Usual activities 0.710*
ASMI 2SD −0.111 1.354 0.895 0.063-12.791 0.935
ASMI 1SD 0.315 0.328 1.370 0.719-2.610 0.338
ASMI 20 −0.014 0.228 0.986 0.630-1.544 0.951
Normal
Pain/discomfort 0.299*
ASMI 2SD −1.274 1.375 0.280 0.019-4.165 0.354
ASMI 1SD −0.082 0.287 0.921 0.524-1.619 0.775
ASMI 20 −0.306 0.192 0.737 0.505-1.074 0.112
Normal
Anxiety/depression 0.754*
ASMI 2SD −0.754 1.210 0.470 0.044-5.070 0.534
ASMI 1SD 0.177 0.309 1.194 0.651-2.190 0.566
ASMI 20 −0.248 0.279 0.780 0.451-1.349 0.374
Normal
EQ5D index 0.490*
ASMI 2SD −1.828 1.427 0.161 0.010-2.652 0.201
ASMI 1SD 0.113 0.317 1.120 0.601-2.085 0.721
ASMI 20 −0.182 0.234 0.833 0.527-1.319 0.436
Normal
The weighted sample size reflects the number of objects and the sample weights. 95% CI: 95%.
Confidential Index for Cumulative Odds Ratio. *Adjustment for multiple comparisons was performed using the Sequential Sidak method for obesity criteria, family
income, education, smoking, alcohol consumption criteria (AUDIT-K), chronic illness (cancer, diabetes, hypertension, stroke, coronary artery disease, arthritis,
chronic pulmonary disease, depression, chronic renal failure, chronic viral hepatitis/ liver cirrhosis), and Number of chronic disease. Low ASMI groups were
defined as subjects whose ASMIs were lower than the following three cutoff points: ASMI 2SD - the value of the lowest 2.28% of the gender-specific young
reference group, ASMI 1SD - the value of the lowest 15.87% of the gender-specific young reference group, and ASMI 20 - the value of lowest 20% of the
gender-specific old age study group.
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http://www.biomedcentral.com/1471-2318/14/144Conclusions
Among Korean older people, the prevalence of low ASM
was 9.7% in men and only 0.7% in women when an ASMI
2SD cutoff point of 6.09 kg/m2 was used for men and
4.38 kg/m2 for women, which lowers its clinical usefulness
because of the extremely low determined prevalence in
women. Hence, we suggest that the cutoff point of the
lowest 20% of Korean older people (men: 6.48 kg/m2,
women; 5.33 kg/m2) be used for older Korean people.Competing interests
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